Approvals/CIMA-AEMPS/DESVENLAFAXINA NEURAXPHARM 100 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG

Approved

STANDARD

DESVENLAFAXINA NEURAXPHARM 100 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG

Neuraxpharm Spain S.L.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 1ff573897ff93c0e
Drug Cima Aemps Name: DESVENLAFAXINA NEURAXPHARM 100 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG
Register Number: 86784
Holder Company Name: Neuraxpharm Spain S.L.
Marketing Company Name: Neuraxpharm Spain S.L.
Authorization Date: 2022-04-04
Dosage Form: COMPRIMIDO DE LIBERACIÓN PROLONGADA
Dose: 100 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Neuraxpharm Spain S.L.

DESVENLAFAXINA BENZOATO

146,32 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Apr 4, 2022

Approval ID

1ff573897ff93c0e

Type

Standard